ログイン

FINALS FINALE
47問 • 7ヶ月前
  • E
  • 通報

    問題一覧

  • 1

    The fluid and electrolyte balance in the body is called .

    Homeostasis

  • 2

    one of the important constituents ofour body fluid, which constitutes about 7% of body weight

    Blood

  • 3

    also known as intravenous solutions, are supplemental fluids used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route is not possible.

    Intravenous fluids

  • 4

    are homogeneous non-crystalline substances containing large molecules or ultramicroscopic particles of one substance dispersed ni asecond substance.

    Colloids

  • 5

    aqueous solutions of salts or minerals that can be crystallized.

    Crystalloids

  • 6

    Categorize 3 IV fluids based on their TONICITY HIH

    - Hypertonic - Isotonic - Hypotonic

  • 7

    solutions that exert the same osmotic pressure as that of plasma • Normal saline 0.9% • Ringers lactate • Blood components

    Isotonic

  • 8

    A solution that exerts less osmotic pressure than that of blood plasma • Dextrose 5% and water

    Hypotonic

  • 9

    The solution exerts higher osmotic pressure than that of plasma e.g.

    Hypertonic

  • 10

    5 IV Solutions can also be CLASSIFIED on their PURPOSE NEAAV

    - Nutrient Solutions - Electrolyte Solutions - Alkalinizing Solutions - Acidifying Solutions - Volume Expanders

  • 11

    • May contain dextrose, glucose, and levulose to make up the carbohydrate component - and water. • useful in preventing dehydration and ketosis. Examples include DSW, D5NSS.

    Nutrient solutions

  • 12

    Contains varying amounts of cations and anions that are used to replace fluid and electrolytes for clients with continuing losses. Examples include 0.9 NaCl, Ringer's Solution, and LRS.

    Electrolyte solutions

  • 13

    Are administered to treat metabolic acidosis. Examples: LRS.

    Alkalinizing solutions

  • 14

    Are used to counteract metabolic alkalosis. D51/2NS, 0.9 NaCl.

    Acidifying solutions

  • 15

    Are solutions used to increase the blood volume after a severe blood loss, or loss of plasma. Examples are dextran, human albumin, and plasma.

    Volume expanders

  • 16

    COMPONENTS OF FLUIDS • Saline solution - water and electrolyte. • Dextrose solution -water or saline and sugar. • Ringers lactate -water and electrolyte and sugar. • Balance isotonic -It has water, electrolyte and some sugar. • Whole blood and blood components. Plasma expanders - albumin, dextrin, plasma, protein fraction plasmanate)

    REVIEW

  • 17

    When infused, ______ _____ expand both the intracellular fluid and extracellular fluid spaces, equally. Such fluids do not alter the osmolality of the vascular compartment.

    Isotonic solutions

  • 18

    is a crystalloid isotonic VI fluid that contains water, sodium (154 mEq/L), and chloride (154 mEq/L).

    NSS 0.9% NaCl

  • 19

    is the isotonic solution of choice for expanding the extracellular fluid (ECF) volume because it does not enter the intracellular fluid (ICF).

    Normal saline

  • 20

    It is administered to supply water and to correct an increase in serum osmolality. It should not be used for fluid resuscitation because hyperglycaemia can result. It should also be avoided to be used in clients at risk for increased intracranial pressure as it can cause cerebral oedema.

    D5W

  • 21

    • crystalloid isotonic IV fluid designed to be the near-physiological solution of balanced electrolytes • it also contains bicarbonate precursors to prevent acidosis. It does not provide calories or magnesium and has limited potassium replacement. It is the most physiologically adaptable fluid because its electrolyte content is most closely related to the composition of the body's blood serum and plasma.

    Lactated Ringer’s D5W

  • 22

    The general nursing interventions and considerations when administering isotonic solutions: • Documentbaselinedata. Before infusion, assess the patient's vital signs, edema status, lung sounds, and heart sounds. Continue monitoring during and after the infusion. • Observeforsignsoffluidoverload. Look for signs of hypervolemia such as hypertension, bounding pulse, pulmonary crackles, dyspnea, shortness of breath, peripheral edema, jugular venous distention, and extra heart sounds. • Monitormanifestationsofcontinuedhypovolemia. Look for signs that indicate continued hypovolemia such as, decreased urine output, poor skin turgor, tachycardia, weak pulse, and hypotension. • Prevent hypervolemia. Patients being treated for hypovolemia can quickly develop fluid overload following rapid or over infusion of isotonic VI fluids. • Elevatetheheadofthebedat35to45degrees. Unless contraindicated, position the client in semi-Fowler's position. Elevatethepatient'slegs.If edema is present, elevate the legs of the patient to promote venous return. Educatepatients and families. Teach patients and families to recognize signs and symptoms of fluid volume overload. Instruct patients to notify their nurse if they have trouble breathing or notice any swelling. • Closemonitoringforpatientswithheartfailure.Because isotonic fluids expand the intravascular space, patients with hypertension and heart failure should be carefully monitored for signs of fluid overload

    STUDY

  • 23

    solution derived from plasma and is a commonly utilized colloid solution. It is used to increase the circulating volume and restore protein levels ni conditions such as burns, pancreatitis, and plasma loss through trauma.

    5% Albumin

  • 24

    used together with sodium and water restriction to reduce excessive oedema. They are considered blood transfusion products and uses the same protocols and nursing precautions when administering albumin.

    25% Albumin

  • 25

    polysaccharides that act as colloids. - available in either saline or glucose solutions. Dextran interferes with blood crossmatching, so draw the patient's blood before administering dextran, if crossmatching is anticipated.

    Dextrans

  • 26

    contains polysaccharide molecules that behave like colloids with an average molecular weight. - used to improve the microcirculation in patients with poor peripheral circulation. They contain no electrolytes and are used to treat shock related to vascular volume loss

    LMWD

  • 27

    used for patients with hypovolemia and hypotension. They are contraindicated in patients with hemorrhagic shock.

    HMWD

  • 28

    These solutions are derived from starch and are used to increase intravascular fluid but can interfere with normal coagulation.

    Etherfied starch

  • 29

    have lower molecular weight than dextrans and therefore remain in the circulation for a shorter period of time.

    Gelatin

  • 30

    solution that is also prepared from plasma, and like albumin, is heated before infusion. It is recommended to infuse slowly to increase circulating volume.

    Plasma Protein Fraction

  • 31

    It is the science that deals with the effects of drugs on living system

    Pharmacology

  • 32

    'any substance or product that is used or intended to be used to modify or explore physiological systems or pathological states for the benefit of the recipient'

    Drug

  • 33

    movement of the drug within the body it includes the processes of absorption (A), distribution (D), metabolism (M) and excretion (E). It means 'what the body does to the drug.

    Pharmacokinetics

  • 34

    study of drugs-their mechanism of action, pharmacological actions and their adverse effects, It covers all the aspects relating to what the drug does to the body".

    Pharmacodynamics

  • 35

    branch of science that deals with the preparation, preservation, standardization, compounding and proper utilization of drugs.

    Pharmacy

  • 36

    It is the aspect of medicine that is concerned with the treatment of diseases.

    Therapeutics

  • 37

    deals with the treatment of infectious diseases/cancer with chemical compounds that have relatively selective toxicity for the infecting organism/ cancer cells

    Chemotherapy

  • 38

    study of poisons, their actions, detection, prevention and the treatment of poisoning.

    Toxicology

  • 39

    systematic study of a drug in humans-both in healthy volunteers and patients. It includes the evaluation of pharmacokinetic and pharmacodynamic data, safety, effi cacy and adverse effects of a drug by comparative clinical trials.

    Clinical pharmacology

  • 40

    those that satisfy the healthcare needs of majority of the population". They should be of assured quality, available at all times in adequate quantities and in appropriate dosage forms.

    Essential medicine

  • 41

    Drugs that are used for the diagnosis, treatment or prevention of rare diseases. The expenses incurred during the development, manufacture and marketing of drug cannot be recovered from selling the drugs by the pharmaceutical company,

    Orphan drugs

  • 42

    can be sold to a patient without the need for a doctor's prescription, e.B. paracetamol, antacids, etc.

    OTC Drugs

  • 43

    These are the drugs that can be obtained only upon producing a prescription by a registered medical practitioner, e.g. antibiotics, antipsychotics, etc.

    Prescription drugs

  • 44

    6 DIFFERENT SOURCES OF DRUGS PAMMSS

    - Plants - Animals - Minerals - Microorganisms - Semisynthetic - Synthetic

  • 45

    what Systemic route: Inhalation, Injections, Transderma.

    Parenteral

  • 46

    what Systemic route: : Oral, Sublingual, Rectal etc.

    Enteral

  • 47

    Routes are mainly categorised into L&S

    Local and Systemic Local - administration of a drug at the site where the desired action is required

  • physiology of circulation academic weaponizer

    physiology of circulation academic weaponizer

    E · 24問 · 2年前

    physiology of circulation academic weaponizer

    physiology of circulation academic weaponizer

    24問 • 2年前
    E

    reproductive academic weaponizer

    reproductive academic weaponizer

    E · 55問 · 2年前

    reproductive academic weaponizer

    reproductive academic weaponizer

    55問 • 2年前
    E

    cells prelim acad weaponizer

    cells prelim acad weaponizer

    E · 24問 · 2年前

    cells prelim acad weaponizer

    cells prelim acad weaponizer

    24問 • 2年前
    E

    respiratory/body cavities prelim acad weaponizer

    respiratory/body cavities prelim acad weaponizer

    E · 20問 · 2年前

    respiratory/body cavities prelim acad weaponizer

    respiratory/body cavities prelim acad weaponizer

    20問 • 2年前
    E

    integumentary prelim acad weaponizer

    integumentary prelim acad weaponizer

    E · 29問 · 2年前

    integumentary prelim acad weaponizer

    integumentary prelim acad weaponizer

    29問 • 2年前
    E

    skeletal prelim acad weaponizer

    skeletal prelim acad weaponizer

    E · 33問 · 2年前

    skeletal prelim acad weaponizer

    skeletal prelim acad weaponizer

    33問 • 2年前
    E

    tissue prelim acad weaponizer

    tissue prelim acad weaponizer

    E · 42問 · 2年前

    tissue prelim acad weaponizer

    tissue prelim acad weaponizer

    42問 • 2年前
    E

    membrane prelim acad weaponizer

    membrane prelim acad weaponizer

    E · 20問 · 2年前

    membrane prelim acad weaponizer

    membrane prelim acad weaponizer

    20問 • 2年前
    E

    RPC L2

    RPC L2

    E · 28問 · 1年前

    RPC L2

    RPC L2

    28問 • 1年前
    E

    RPC L3

    RPC L3

    E · 40問 · 1年前

    RPC L3

    RPC L3

    40問 • 1年前
    E

    RPC L4

    RPC L4

    E · 32問 · 1年前

    RPC L4

    RPC L4

    32問 • 1年前
    E

    ALE

    ALE

    E · 48問 · 1年前

    ALE

    ALE

    48問 • 1年前
    E

    RPC L5

    RPC L5

    E · 64問 · 1年前

    RPC L5

    RPC L5

    64問 • 1年前
    E

    RPC M1

    RPC M1

    E · 38問 · 1年前

    RPC M1

    RPC M1

    38問 • 1年前
    E

    RPC M1/2

    RPC M1/2

    E · 45問 · 1年前

    RPC M1/2

    RPC M1/2

    45問 • 1年前
    E

    RPC M2

    RPC M2

    E · 64問 · 1年前

    RPC M2

    RPC M2

    64問 • 1年前
    E

    RPC M2.5

    RPC M2.5

    E · 45問 · 1年前

    RPC M2.5

    RPC M2.5

    45問 • 1年前
    E

    RPC M3

    RPC M3

    E · 51問 · 1年前

    RPC M3

    RPC M3

    51問 • 1年前
    E

    問題一覧

  • 1

    The fluid and electrolyte balance in the body is called .

    Homeostasis

  • 2

    one of the important constituents ofour body fluid, which constitutes about 7% of body weight

    Blood

  • 3

    also known as intravenous solutions, are supplemental fluids used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route is not possible.

    Intravenous fluids

  • 4

    are homogeneous non-crystalline substances containing large molecules or ultramicroscopic particles of one substance dispersed ni asecond substance.

    Colloids

  • 5

    aqueous solutions of salts or minerals that can be crystallized.

    Crystalloids

  • 6

    Categorize 3 IV fluids based on their TONICITY HIH

    - Hypertonic - Isotonic - Hypotonic

  • 7

    solutions that exert the same osmotic pressure as that of plasma • Normal saline 0.9% • Ringers lactate • Blood components

    Isotonic

  • 8

    A solution that exerts less osmotic pressure than that of blood plasma • Dextrose 5% and water

    Hypotonic

  • 9

    The solution exerts higher osmotic pressure than that of plasma e.g.

    Hypertonic

  • 10

    5 IV Solutions can also be CLASSIFIED on their PURPOSE NEAAV

    - Nutrient Solutions - Electrolyte Solutions - Alkalinizing Solutions - Acidifying Solutions - Volume Expanders

  • 11

    • May contain dextrose, glucose, and levulose to make up the carbohydrate component - and water. • useful in preventing dehydration and ketosis. Examples include DSW, D5NSS.

    Nutrient solutions

  • 12

    Contains varying amounts of cations and anions that are used to replace fluid and electrolytes for clients with continuing losses. Examples include 0.9 NaCl, Ringer's Solution, and LRS.

    Electrolyte solutions

  • 13

    Are administered to treat metabolic acidosis. Examples: LRS.

    Alkalinizing solutions

  • 14

    Are used to counteract metabolic alkalosis. D51/2NS, 0.9 NaCl.

    Acidifying solutions

  • 15

    Are solutions used to increase the blood volume after a severe blood loss, or loss of plasma. Examples are dextran, human albumin, and plasma.

    Volume expanders

  • 16

    COMPONENTS OF FLUIDS • Saline solution - water and electrolyte. • Dextrose solution -water or saline and sugar. • Ringers lactate -water and electrolyte and sugar. • Balance isotonic -It has water, electrolyte and some sugar. • Whole blood and blood components. Plasma expanders - albumin, dextrin, plasma, protein fraction plasmanate)

    REVIEW

  • 17

    When infused, ______ _____ expand both the intracellular fluid and extracellular fluid spaces, equally. Such fluids do not alter the osmolality of the vascular compartment.

    Isotonic solutions

  • 18

    is a crystalloid isotonic VI fluid that contains water, sodium (154 mEq/L), and chloride (154 mEq/L).

    NSS 0.9% NaCl

  • 19

    is the isotonic solution of choice for expanding the extracellular fluid (ECF) volume because it does not enter the intracellular fluid (ICF).

    Normal saline

  • 20

    It is administered to supply water and to correct an increase in serum osmolality. It should not be used for fluid resuscitation because hyperglycaemia can result. It should also be avoided to be used in clients at risk for increased intracranial pressure as it can cause cerebral oedema.

    D5W

  • 21

    • crystalloid isotonic IV fluid designed to be the near-physiological solution of balanced electrolytes • it also contains bicarbonate precursors to prevent acidosis. It does not provide calories or magnesium and has limited potassium replacement. It is the most physiologically adaptable fluid because its electrolyte content is most closely related to the composition of the body's blood serum and plasma.

    Lactated Ringer’s D5W

  • 22

    The general nursing interventions and considerations when administering isotonic solutions: • Documentbaselinedata. Before infusion, assess the patient's vital signs, edema status, lung sounds, and heart sounds. Continue monitoring during and after the infusion. • Observeforsignsoffluidoverload. Look for signs of hypervolemia such as hypertension, bounding pulse, pulmonary crackles, dyspnea, shortness of breath, peripheral edema, jugular venous distention, and extra heart sounds. • Monitormanifestationsofcontinuedhypovolemia. Look for signs that indicate continued hypovolemia such as, decreased urine output, poor skin turgor, tachycardia, weak pulse, and hypotension. • Prevent hypervolemia. Patients being treated for hypovolemia can quickly develop fluid overload following rapid or over infusion of isotonic VI fluids. • Elevatetheheadofthebedat35to45degrees. Unless contraindicated, position the client in semi-Fowler's position. Elevatethepatient'slegs.If edema is present, elevate the legs of the patient to promote venous return. Educatepatients and families. Teach patients and families to recognize signs and symptoms of fluid volume overload. Instruct patients to notify their nurse if they have trouble breathing or notice any swelling. • Closemonitoringforpatientswithheartfailure.Because isotonic fluids expand the intravascular space, patients with hypertension and heart failure should be carefully monitored for signs of fluid overload

    STUDY

  • 23

    solution derived from plasma and is a commonly utilized colloid solution. It is used to increase the circulating volume and restore protein levels ni conditions such as burns, pancreatitis, and plasma loss through trauma.

    5% Albumin

  • 24

    used together with sodium and water restriction to reduce excessive oedema. They are considered blood transfusion products and uses the same protocols and nursing precautions when administering albumin.

    25% Albumin

  • 25

    polysaccharides that act as colloids. - available in either saline or glucose solutions. Dextran interferes with blood crossmatching, so draw the patient's blood before administering dextran, if crossmatching is anticipated.

    Dextrans

  • 26

    contains polysaccharide molecules that behave like colloids with an average molecular weight. - used to improve the microcirculation in patients with poor peripheral circulation. They contain no electrolytes and are used to treat shock related to vascular volume loss

    LMWD

  • 27

    used for patients with hypovolemia and hypotension. They are contraindicated in patients with hemorrhagic shock.

    HMWD

  • 28

    These solutions are derived from starch and are used to increase intravascular fluid but can interfere with normal coagulation.

    Etherfied starch

  • 29

    have lower molecular weight than dextrans and therefore remain in the circulation for a shorter period of time.

    Gelatin

  • 30

    solution that is also prepared from plasma, and like albumin, is heated before infusion. It is recommended to infuse slowly to increase circulating volume.

    Plasma Protein Fraction

  • 31

    It is the science that deals with the effects of drugs on living system

    Pharmacology

  • 32

    'any substance or product that is used or intended to be used to modify or explore physiological systems or pathological states for the benefit of the recipient'

    Drug

  • 33

    movement of the drug within the body it includes the processes of absorption (A), distribution (D), metabolism (M) and excretion (E). It means 'what the body does to the drug.

    Pharmacokinetics

  • 34

    study of drugs-their mechanism of action, pharmacological actions and their adverse effects, It covers all the aspects relating to what the drug does to the body".

    Pharmacodynamics

  • 35

    branch of science that deals with the preparation, preservation, standardization, compounding and proper utilization of drugs.

    Pharmacy

  • 36

    It is the aspect of medicine that is concerned with the treatment of diseases.

    Therapeutics

  • 37

    deals with the treatment of infectious diseases/cancer with chemical compounds that have relatively selective toxicity for the infecting organism/ cancer cells

    Chemotherapy

  • 38

    study of poisons, their actions, detection, prevention and the treatment of poisoning.

    Toxicology

  • 39

    systematic study of a drug in humans-both in healthy volunteers and patients. It includes the evaluation of pharmacokinetic and pharmacodynamic data, safety, effi cacy and adverse effects of a drug by comparative clinical trials.

    Clinical pharmacology

  • 40

    those that satisfy the healthcare needs of majority of the population". They should be of assured quality, available at all times in adequate quantities and in appropriate dosage forms.

    Essential medicine

  • 41

    Drugs that are used for the diagnosis, treatment or prevention of rare diseases. The expenses incurred during the development, manufacture and marketing of drug cannot be recovered from selling the drugs by the pharmaceutical company,

    Orphan drugs

  • 42

    can be sold to a patient without the need for a doctor's prescription, e.B. paracetamol, antacids, etc.

    OTC Drugs

  • 43

    These are the drugs that can be obtained only upon producing a prescription by a registered medical practitioner, e.g. antibiotics, antipsychotics, etc.

    Prescription drugs

  • 44

    6 DIFFERENT SOURCES OF DRUGS PAMMSS

    - Plants - Animals - Minerals - Microorganisms - Semisynthetic - Synthetic

  • 45

    what Systemic route: Inhalation, Injections, Transderma.

    Parenteral

  • 46

    what Systemic route: : Oral, Sublingual, Rectal etc.

    Enteral

  • 47

    Routes are mainly categorised into L&S

    Local and Systemic Local - administration of a drug at the site where the desired action is required